Promega
Promega to Develop Microsatellite Instability Companion Diagnostic Kit With GlaxoSmithKline
The IVD kit will be used to identify patients with the MSI biomarker who may be eligible for potential treatment with GSK's Jemperli (dostarlimab-gxly).
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.
FDA Clears Promega Microsatellite Instability Test System
The OncoMate MSI Dx Analysis System is used to diagnose Lynch syndrome, a hereditary condition that increases cancer risk.
Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug
Promega will develop its microsatellite instability assay as a companion diagnostic for Incyte's anti-PD-1 drug candidate retifanlimab in endometrial cancer.
Merck, Promega Collaborate to Develop MSI CDx for Keytruda
Promega's microsatellite instability technology will be used to develop an on-label, solid tumor companion diagnostic for pembrolizumab.